Fortress Biotech (FBIO) News Today $1.61 +0.04 (+2.55%) (As of 11/22/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period What is HC Wainwright's Estimate for FBIO Q4 Earnings?November 21 at 2:07 AM | americanbankingnews.comFortress Biotech price target raised to $15 from $13 at Roth MKMNovember 20 at 7:57 AM | markets.businessinsider.comFortress Biotech (NASDAQ:FBIO) Rating Lowered to "Sell" at StockNews.comNovember 19, 2024 | americanbankingnews.comFortress Biotech price target raised to $26 from $24 at H.C. WainwrightNovember 18, 2024 | markets.businessinsider.comFortress Biotech price target lowered to $4 from $5 at Alliance Global PartnersNovember 18, 2024 | markets.businessinsider.comFortress Biotech (NASDAQ: FBIO) Issues Corporate Update and Reports Financial Results for Q3 2024November 16, 2024 | americanbankingnews.comFortress Biotech’s Q3 2024 Earnings and FDA MilestoneNovember 15, 2024 | markets.businessinsider.comFortress Biotech Reports Third Quarter 2024 Financial Results and Recent Corporate HighlightsNovember 14, 2024 | globenewswire.comCheckpoint Therapeutics Reports Third Quarter 2024 Financial Results and Recent Corporate UpdatesNovember 12, 2024 | globenewswire.comJourney Medical Corporation Reports Third Quarter 2024 Financial Results and Recent Corporate HighlightsNovember 12, 2024 | globenewswire.comJourney Medical Corporation Announces U.S. FDA Approval of Emrosi™ (Minocycline Hydrochloride Extended Release Capsules, 40 mg) for the Treatment of RosaceaNovember 4, 2024 | globenewswire.comHighbridge Capital Management's Strategic Acquisition of Fortress Biotech SharesOctober 25, 2024 | uk.finance.yahoo.comJourney Medical Corporation Announces DFD-29 Data Presented at 44th Fall Clinical Dermatology ConferenceOctober 25, 2024 | globenewswire.comJourney Medical Corporation to Participate in the 3rd Annual ROTH Healthcare Opportunities ConferenceOctober 3, 2024 | globenewswire.comFortress Biotech to Participate in October 2024 Investor ConferencesSeptember 26, 2024 | globenewswire.comLindsay A. Md Rosenwald Buys 763,359 Shares of Fortress Biotech, Inc. (NASDAQ:FBIO) StockSeptember 26, 2024 | insidertrades.comFortress Biotech secures $8 million in stock salesSeptember 22, 2024 | investing.comWhy Fortress Biotech (FBIO) Stock Is Getting HammeredSeptember 20, 2024 | msn.comFortress Biotech Announces Pricing of $8 Million Registered Direct Offering and Concurrent Private PlacementsSeptember 20, 2024 | globenewswire.comCheckpoint Therapeutics Announces Cosibelimab Longer-Term Results in Advanced Cutaneous Squamous Cell Carcinoma Presented at ESMO Congress 2024September 16, 2024 | globenewswire.comJourney Medical Corporation to Participate in the Lake Street Capital Markets 8th Annual Best Ideas Growth (BIG) ConferenceSeptember 9, 2024 | globenewswire.comFortress Biotech to Present at the H.C. Wainwright 26th Annual Global Investment ConferenceSeptember 4, 2024 | globenewswire.comJourney Medical Corporation to Present at the H.C. Wainwright 26th Annual Global Investment ConferenceSeptember 4, 2024 | globenewswire.comCheckpoint Therapeutics to Present at H.C. Wainwright 26th Annual Global Investment ConferenceSeptember 4, 2024 | globenewswire.comFBIO Sep 2024 5.000 call (FBIO240920C00005000)August 18, 2024 | finance.yahoo.comFortress Biotech Reports Second Quarter 2024 Financial Results and Recent Corporate HighlightsAugust 13, 2024 | globenewswire.comJourney Medical Corporation Reports Second Quarter 2024 Financial Results and Recent Corporate HighlightsAugust 12, 2024 | globenewswire.comCheckpoint Therapeutics Reports Second Quarter 2024 Financial Results and Recent Corporate UpdatesAugust 12, 2024 | globenewswire.comJourney Medical Corporation to Announce Second Quarter 2024 Financial Results on August 12, 2024August 6, 2024 | globenewswire.comFortress Biotech Reduces Total Debt and Enters into New $35 Million Term Loan with Oaktree with Maturity in 2027July 25, 2024 | globenewswire.comCheckpoint Therapeutics Announces FDA Acceptance of BLA Resubmission of Cosibelimab for the Treatment of Advanced Cutaneous Squamous Cell CarcinomaJuly 25, 2024 | globenewswire.comFortress Biotech’s Strategic Financial Moves and Clinical Pipeline Promise Bright Revenue Prospects: Pantginis Issues Buy RatingJuly 19, 2024 | markets.businessinsider.comLindsay A. Md Rosenwald Acquires 5,000 Shares of Fortress Biotech, Inc. (NASDAQ:FBIO) StockJuly 16, 2024 | insidertrades.comGC Cell and Checkpoint Therapeutics Advance Collaborative Cancer ResearchJuly 15, 2024 | globenewswire.comJourney Medical Corporation Appoints Michael C. Pearce to Board of DirectorsJuly 11, 2024 | globenewswire.comFortress Biotech Announces Pause in Payment of Dividends on 9.375% Series A Cumulative Redeemable Perpetual Preferred StockJuly 5, 2024 | globenewswire.comCheckpoint Therapeutics Announces $12 Million Registered Direct Offering Priced At-the-Market Under Nasdaq RulesJuly 2, 2024 | globenewswire.comCheckpoint Therapeutics Announces Biologics License Application Resubmission for CosibelimabJuly 2, 2024 | globenewswire.comLindsay A. Md Rosenwald Buys 20,000 Shares of Fortress Biotech, Inc. (NASDAQ:FBIO) StockJuly 2, 2024 | insidertrades.comCheckpoint Therapeutics Announces Alignment with FDA Enabling Upcoming Cosibelimab BLA ResubmissionJune 24, 2024 | globenewswire.comInsider Buying: Fortress Biotech, Inc. (NASDAQ:FBIO) CEO Buys 10,000 Shares of StockMay 21, 2024 | insidertrades.comAnalysts Are Bullish on Top Healthcare Stocks: Fortress Biotech (FBIO), BioLife Solutions (BLFS)May 16, 2024 | markets.businessinsider.comFortress Biotech, Inc.: Fortress Biotech Reports First Quarter 2024 Financial Results and Recent Corporate HighlightsMay 16, 2024 | finanznachrichten.deFortress Biotech to Participate in the Alliance Global Partners’ (A.G.P.) Virtual Healthcare Company ShowcaseMay 16, 2024 | finance.yahoo.comAvenue Therapeutics Announces Last Patient Last Visit in Phase 1b/2a Clinical Trial of AJ201 for the Treatment of Spinal and Bulbar Muscular Atrophy (Kennedy's Disease)May 16, 2024 | finance.yahoo.comFortress Biotech to Participate in the Alliance Global Partners' (A.G.P.) Virtual Healthcare Company ShowcaseMay 16, 2024 | globenewswire.comFortress Biotech Reports First Quarter 2024 Financial Results and Recent Corporate HighlightsMay 15, 2024 | globenewswire.comJourney Medical Corporation to Participate in the Alliance Global Partners' (A.G.P.) Virtual Healthcare Company ShowcaseMay 15, 2024 | globenewswire.comFortress Biotech Announces First Patient Dosed in Multi-Center Phase 2 Study of Triplex for Control of CMV in Patients Undergoing Liver TransplantationMay 14, 2024 | globenewswire.comJourney Medical Corporation Reports First Quarter 2024 Financial Results and Recent Corporate HighlightsMay 13, 2024 | globenewswire.com Get Fortress Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for FBIO and its competitors with MarketBeat's FREE daily newsletter. Email Address 2024 Election Year Stocks: Uncover Hidden Gems! (Ad)In the lead-up to the pivotal 2024 election year, we're excited to present our comprehensive report, "Election Year Investment Gems: Stock Poised To Takeoff In 2024," brimming with insights and opportunities you won't want to miss. Secure your copy now by clicking this link. FBIO Media Mentions By Week FBIO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. FBIO News Sentiment▼-0.040.49▲Average Medical News Sentiment FBIO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. FBIO Articles This Week▼131▲FBIO Articles Average Week Get Fortress Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for FBIO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies CMRX News ACHV News RGLS News AGEN News SABS News CRIS News BOLT News MTEM News NATR News AQST News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:FBIO) was last updated on 11/23/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fortress Biotech, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Fortress Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
